Exploring and Validating Prognostic BiomarkersRelated to Sphingolipid Metabolism in Gastric Cancerthrough Machine Learning
Bioinformatics analysis and IHC validation suggest that ELOVL4 expression may serve as a prognostic biomarker for GC, providing new insights for prognosis prediction and therapeutic target development in gastric cancer.
Authors
- Xing Guo (ORCID: https://orcid.org/0000-0002-4111-4640)
- Ce Guo (ORCID: https://orcid.org/0000-0002-6042-1216)
- Yang Yu (ORCID: https://orcid.org/0000-0001-8290-2080)
- Jian Chai (ORCID: https://orcid.org/0000-0003-1280-0665)
- Xiaolong Li (ORCID: https://orcid.org/0000-0002-6450-1184)
- Huiqing Zhang (ORCID: https://orcid.org/0000-0002-9137-9671)
- Jiajie Wei
- Haodi Wang
Institutions
- Affiliated Hospital of Chengde Medical College (CN)
- Baoding People's Hospital (CN)
Publication Details
- Journal
- Endocrine Metabolic & Immune Disorders - Drug Targets
- Published
- 2025-03-26
- DOI
- https://doi.org/10.2174/0118715303362774250219065927
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00